Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering

Contributed by: Business Wire

Logo

Tags

Professional Services

Health

Finance

General Health

Pharmaceutical

Biotechnology

Silence Therapeutics plc

More Like This

Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares

Silence Therapeutics Announces Oversubscribed $120 Million Private Placement

Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference

Silence Therapeutics to Participate in Jefferies Global Healthcare Conference

Silence Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights

Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Silence Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update